Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | Fluvoxamine@LNP-TFR Peptide, Fluvoxamine@lipid nanoparticles-transferrin receptor peptide |
| Catalog Number | R-FLNT |
| Alias | Fluvoxamine-lipid nanoparticles-TFR peptide |
| Appearance | Milky white or translucent liquid |
| Molecular Formula | N/A |
| Solubility | Soluble in organic solvents |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 year |
| Shipping Condition | low temperature transport |
| Application | drug delivery system |
| Specification | 10mg:Inquiry 25mg:Inquiry 50mg:Inquiry |
| Description | In terms of physical properties of fluvoxamine@LNP-TFR peptide, the overall product appearance may be milky white or translucent liquid, which mainly depends on the formulation of lipid nanoparticles (LNP). LNPs serve as carriers and usually have specific stability and solubility to ensure the payload of fluvoxamine and peptides. Fluvoxamine itself is a white to off-white crystalline powder, but its physical state changes after it is combined with LNP and peptides to form a complex. The physical properties of the peptide moiety depend on its amino acid sequence and molecular weight, and may have different solubility and stability characteristics. The complex aims to achieve targeted delivery of fluvoxamine through LNP, using the targeting properties of TFR peptides to increase the concentration of the drug in specific cells or tissues. Since it is a complex, the overall physical properties need to be determined based on the specific formula and preparation process, including key parameters such as particle size, zeta potential, encapsulation efficiency, etc. These parameters are crucial for evaluating the stability and delivery efficiency of the complex. |